SHR-1210
E2017232
Phase 2 mab active
Quick answer
SHR-1210 for Renal Cell Carcinoma is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Renal Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active